Working… Menu

The Study to Evaluate Toripalimab (JS001) in Patients With Advanced GC, ESCC, NPC, HNSCC

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02915432
Recruitment Status : Active, not recruiting
First Posted : September 27, 2016
Last Update Posted : October 23, 2019
Information provided by (Responsible Party):
Shanghai Junshi Bioscience Co., Ltd.